How do I bill for take-home naloxone?

Having trouble viewing this email? View it as a Web page.

Health Care Authority (HCA) logo

How do I bill for take-home naloxone? 

In response to the increase in opioid overdose-related deaths in Washington State, the legislature passed Senate Bill 5195 (chapter 273, Laws of 2021). This law helps to increase access to naloxone for all individuals at risk of an opioid overdose. The law requires distribution of prepackaged (take-home) naloxone to individuals at risk of an opioid overdose at:

  • Hospital emergency departments (EDs)
  • Pharmacies
  • Opioid treatment programs
  • Certified or licensed behavioral health agencies (BHAs) that provide any of the following services:
    • Treatment for mental health or substance use disorders
    • Secure withdrawal management
    • Evaluation and treatment

Retroactive to dates of service on and after January 1, 2022, hospital EDs, opioid treatment programs and certified or licensed BHAs may be reimbursed for prepackaged opioid overdose reversal medication, naloxone, distributed to clients at risk of an opioid overdose. Naloxone distributed to Apple Health Fee-For-Service (FFS) clients may be billed with one of the following HCPCS and the National Drug Code (NDC) of the product distributed:

HCPCS Drug
J2310 Naloxone injection
G2215 Naloxone 4mg nasal spray
G1028 Naloxone 8mg nasal spray

Note:

  • When provided in the ED, take-home naloxone must be billed as a separate line item. HCA does not package naloxone when provided in the ED.
  • When provided by a Behavioral Health Agency, take-home naloxone must be billed as a separate claim.

See the Prescription Drug Program Billing Guide for more information.

For questions, please email us at AppleHealthPharmacyPolicy@hca.wa.gov.